Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

por Bowers, Jacob S., Bailey, Stefanie R., Rubinstein, Mark P., Paulos, Chrystal M., Camp, E. Ramsay
Publicado 2019

Th17 Cells in Cancer: The Ultimate Identity Crisis

por Bailey, Stefanie R., Nelson, Michelle H., Himes, Richard A., Li, Zihai, Mehrotra, Shikhar, Paulos, Chrystal M.
Publicado 2014

Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells

por Pourzia, Alexandra L., Olson, Michael L., Bailey, Stefanie R., Boroughs, Angela C., Aryal, Aditi, Ryan, Jeremy, Maus, Marcela V., Letai, Anthony
Publicado 2023

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies

por Neal, Lillian R., Bailey, Stefanie R., Wyatt, Megan M., Bowers, Jacob S., Majchrzak, Kinga, Nelson, Michelle H., Haupt, Carl, Paulos, Chrystal M., Varela, Juan C.
Publicado 2017

PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells

por Bowers, Jacob S., Majchrzak, Kinga, Nelson, Michelle H., Aksoy, Bulent Arman, Wyatt, Megan M., Smith, Aubrey S., Bailey, Stefanie R., Neal, Lillian R., Hammerbacher, Jeffrey E., Paulos, Chrystal M.
Publicado 2017

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning

por Nelson, Michelle H., Bowers, Jacob S., Bailey, Stefanie R., Diven, Marshall A., Fugle, Caroline W., Kaiser, Andrew D. M., Wrzesinski, Claudia, Liu, Bei, Restifo, Nicholas P., Paulos, Chrystal M.
Publicado 2016

Human CD26(high) T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence

por Bailey, Stefanie R., Nelson, Michelle H., Majchrzak, Kinga, Bowers, Jacob S., Wyatt, Megan M., Smith, Aubrey S., Neal, Lillian R., Shirai, Keisuke, Carpenito, Carmine, June, Carl H., Zilliox, Michael J., Paulos, Chrystal M.
Publicado 2017

Identification of human CD4(+) T cell populations with distinct antitumor activity

por Nelson, Michelle H., Knochelmann, Hannah M., Bailey, Stefanie R., Huff, Logan W., Bowers, Jacob S., Majchrzak-Kuligowska, Kinga, Wyatt, Megan M., Rubinstein, Mark P., Mehrotra, Shikhar, Nishimura, Michael I., Armeson, Kent E., Giresi, Paul G., Zilliox, Michael J., Broxmeyer, Hal E., Paulos, Chrystal M.
Publicado 2020

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

por Choi, Bryan D., Yu, Xiaoling, Castano, Ana P., Darr, Henia, Henderson, Daniel B., Bouffard, Amanda A., Larson, Rebecca C., Scarfò, Irene, Bailey, Stefanie R., Gerhard, Genevieve M., Frigault, Matthew J., Leick, Mark B., Schmidts, Andrea, Sagert, Jason G., Curry, William T., Carter, Bob S., Maus, Marcela V.
Publicado 2019

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources

por Schmidts, Andrea, Marsh, Leah C, Srivastava, Ambike A, Bouffard, Amanda A, Boroughs, Angela C, Scarfò, Irene, Larson, Rebecca C, Bedoya, Felipe, Choi, Bryan D, Frigault, Matthew J, Bailey, Stefanie R, Leick, Mark B, Vatsa, Sonika, Kann, Michael C, Prew, Michelle S, Kleinstiver, Benjamin P, Joung, J Keith, Maus, Marcela V
Publicado 2020

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

por Schmidts, Andrea, Srivastava, Ambike A, Ramapriyan, Rishab, Bailey, Stefanie R, Bouffard, Amanda A, Cahill, Daniel P, Carter, Bob S, Curry, William T, Dunn, Gavin P, Frigault, Matthew J, Gerstner, Elizabeth R, Ghannam, Jack Y, Kann, Michael C, Larson, Rebecca C, Leick, Mark B, Nahed, Brian V, Richardson, Leland G, Scarfò, Irene, Sun, Jing, Wakimoto, Hiroaki, Maus, Marcela V, Choi, Bryan D
Publicado 2022